Seizure Disorder clinical trials
145 active trials name this condition. Describe your situation to see which ones you may be eligible for.
By location
- Subcortical Arousal in Perceptual Awareness
- Medication Treatment of ADHD in Pediatric Epilepsy
- Invasive Decoding and Stimulation of Altered Reward Computations in Depression Patients
- Methylphenidate for the Treatment of Epilepsy-related Cognitive Deficits
- Readiness Brain Operation Optimization Training (ReBOOT) for Epilepsy Surgery
- A Study to Test the Safety and Tolerability of Brivaracetam in Children and Adolescents With Seizures
- Safety and Tolerability Study of SPN-817 in Adult Patients With Treatment Resistant Epilepsy
- Lemborexant Treatment of Insomnia Linked to Epilepsy
- Infrared Photobiomodulation in Humans With Epilepsy
- Effects of Recorded Music on Clinical and EEG Seizure Activity
- Dose Escalation Study to Assess the Safety, Tolerability, Pharmacokinetics And Pharmacodynamics of SIF001 in Healthy Subjects and in Epilepsy Patients
- The Efficacy of a Subanesthetic Doses of IV Ketamine in the Treatment Drug Resistant Epilepsy
- Optimizing Brain Stimulation Parameters
- An Examination of Whether Infrared Light Therapy Can Reduce Stress in People With Epilepsy
- Amygdala Memory Enhancement
- Ketogenic Therapy Effects on Electrical and Metabolic Abnormalities in Epilepsy
- Epilepsy Journey-An Executive Functioning Intervention for Teens With Epilepsy
- A Study to Test the Efficacy and Safety of Staccato Alprazolam in Study Participants 12 Years of Age and Older With Stereotypical Prolonged Seizures
- Effect of Rose Odor Exposure on Ictal Apnea
- The FINTEPLA as an Anti-SUDEP Therapy in Dravet Syndrome Project
- Investigation of Blood-Brain-Barrier Breakdown Using Manganese Magnetic Resonance Imaging in Drug-Resistant Epilepsy
- Sleep-Sensitive Seizure Risk Assessment With Wearable EEGs
- Functional Brain Mapping for Patients with Epilepsy
- Impact of Capturing Ictal Events With Ultra-long-term Ambulatory EEG Monitoring With Remote EEG Monitoring System.
- Diffusion Tensor and Functional Connectivity Imaging in Pediatric Epilepsy: Imaging/Histology Correlation
- Diagnosing Epilepsy To EffeCT Change
- Ear-Seizure Detection (EarSD) Study
- B6 Administration for Levetiracetam-Associated Neurobehavioral Changes and Epilepsy
- Diagnosing Epilepsy To EffeCT Change Long-Term Follow-Up
- PET/MRI/EEG Imaging Study in Epilepsy
- Epilepsy Learning Healthcare System (ELHS)
- Investigating Dynamic Interactions in Distributed Cognitive Control Networks
- ESIS in Pediatric DRE
- Physiological-based Pharmacokinetics Approach to Medication Exposure During Pregnancy and Breastfeeding
- Tumor Related Epilepsy
- Genetics of Epilepsy and Related Disorders
- Risk Factors for Sudden Unexplained Death in Epilepsy
- Brain Metabolism Observed at 3 Tesla or 7 Tesla in Health and Metabolic Disease
- Investigating Epilepsy: Screening and Evaluation
- A Retrospective Survey-based Multicenter Study to Delineate the Molecular and Phenotypic Spectrum of Epilepsy-dyskinesia Syndromes
- Registry and Natural History of Epilepsy-Dyskinesia Syndromes
- Ultra-Low Field (ULF) Point-of-Care (POC) MRI System for Brain Morphology and Pathology
- De-identified UNMH EEG Corpus Database Creation With Fully De-identified Clinical Information
- Surgery as a Treatment for Medically Intractable Epilepsy
- Investigating Phenotypic, Epigenetic, and NeuroGenetic Traits in Rare and Ultra-rare Neurodevelopmental Disorders (Project PENGUIN)
- A Multicenter Pediatric Deep Brain Stimulation Registry
- Patterns of Neurodevelopmental Disorders
- Neural Correlates of Psychiatric Disorders
- Transgenerational Metabolic-Immune Biomarkers of Neurological and Neurodevelopmental Disorders
- Genetic Markers of Cardiovascular Disease in Epilepsy
Guides for people searching for a trial
- Why people get turned down — and what to do nextWhat eligibility criteria are for, what keeps people out, and where to go when the first door closes.
- How your biomarkers decide which trials you qualify forEGFR, HER2, BRAF, PD-L1 and the rest — what they are and why they increasingly gate access.
- How to search for a trial without losing your mindWhere to look, what to gather first, and how to read what you find.
- What Phase 1, 2 and 3 actually mean for youWhat each phase is testing, and how to weigh an early-phase trial against a later one.
- 10 questions to ask before you say yesTreatment, time, cost, safety and your rights. Worth bringing to a screening visit.
- You matched with a trial. What happens now?Phone screens, the screening visit, informed consent, and day one.
Showing active trials that list “Seizure Disorder” as a condition. Eligibility shown on each trial is an estimate — the trial's study team makes the final decision.